TR199701147T1 - Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim. - Google Patents

Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim.

Info

Publication number
TR199701147T1
TR199701147T1 TR97/01147T TR9701147T TR199701147T1 TR 199701147 T1 TR199701147 T1 TR 199701147T1 TR 97/01147 T TR97/01147 T TR 97/01147T TR 9701147 T TR9701147 T TR 9701147T TR 199701147 T1 TR199701147 T1 TR 199701147T1
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
cancers
prevention
development
composition containing
Prior art date
Application number
TR97/01147T
Other languages
English (en)
Inventor
Berger Samden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199701147T1 publication Critical patent/TR199701147T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Memelilerde löseminin tedavisi için bir farmasötik bilesim anlatilmistir. Kullanilan özel fungusid.(I) formülünün bir benzimidazol türevidir. Ayni zamanda, memelilerde tümörler ve kanserlerin büyümesini engelleyen ve kemoterapik maddeler ile bir arada bir fungusid içeren, viral eneksiyonlarin iyilestirilmesi için kullanilabilecek bir farmasötik bilesimde anlatilmistir. Kullanilan özel fungusid bir benzimidazol türevidir. Bileim içine potansiyatörlerde dahil edilebilecektir.
TR97/01147T 1995-04-12 1996-04-11 Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim. TR199701147T1 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42091495A 1995-04-12 1995-04-12
US47381795A 1995-06-07 1995-06-07
US183795P 1995-08-03 1995-08-03

Publications (1)

Publication Number Publication Date
TR199701147T1 true TR199701147T1 (tr) 1998-02-21

Family

ID=27357012

Family Applications (2)

Application Number Title Priority Date Filing Date
TR97/01147T TR199701147T1 (tr) 1995-04-12 1996-04-11 Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim.
TR1998/01562T TR199801562T2 (tr) 1995-04-12 1996-04-11 Viral enfeksiyonlarin iyilestirilmesi için kullanilabilecek benzimidazol içeren bir farmasötik bilesim.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR1998/01562T TR199801562T2 (tr) 1995-04-12 1996-04-11 Viral enfeksiyonlarin iyilestirilmesi için kullanilabilecek benzimidazol içeren bir farmasötik bilesim.

Country Status (19)

Country Link
EP (1) EP0821586B1 (tr)
JP (2) JPH11503459A (tr)
KR (1) KR19980703828A (tr)
CN (1) CN1181010A (tr)
AT (1) ATE242634T1 (tr)
AU (1) AU714078B2 (tr)
BR (1) BR9604974A (tr)
CA (1) CA2217952C (tr)
CZ (1) CZ323497A3 (tr)
DE (1) DE69628645T2 (tr)
HU (1) HUP9801532A3 (tr)
IL (1) IL117875A0 (tr)
NO (1) NO974695L (tr)
NZ (1) NZ305784A (tr)
PL (1) PL322733A1 (tr)
SK (1) SK138497A3 (tr)
TR (2) TR199701147T1 (tr)
TW (1) TW427887B (tr)
WO (1) WO1996032107A1 (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
AU763272B2 (en) * 1997-05-16 2003-07-17 Uaf Technologies And Research Llc Benzimidazole-2-carbamates for the treatment of viral infections and cancer
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
ES2351149T3 (es) 1998-11-09 2011-02-01 Biogen Idec Inc. Anticuerpo quimérico dirigido contra cd20, el rituxan, para uso en el tratamiento de la leucemia linfocítica crónica.
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
WO2003082273A1 (en) 2002-03-26 2003-10-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases
EP1827401A2 (en) 2004-12-10 2007-09-05 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
CN105377355A (zh) 2013-03-14 2016-03-02 拇趾公司 治疗甲单元的感染、疾病或病症的方法
CN103450093A (zh) * 2013-09-06 2013-12-18 中国药科大学 2-苄氨基苯并咪唑类化合物及其用途
CN108383797B (zh) * 2018-03-09 2020-07-21 浙江农林大学 一种防腐化合物及其制备方法与应用
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance

Also Published As

Publication number Publication date
NO974695L (no) 1997-12-08
JP2007284446A (ja) 2007-11-01
EP0821586B1 (en) 2003-06-11
BR9604974A (pt) 1998-06-09
KR19980703828A (ko) 1998-12-05
CA2217952C (en) 2002-06-25
WO1996032107A1 (en) 1996-10-17
EP0821586A1 (en) 1998-02-04
HUP9801532A2 (hu) 1999-01-28
AU714078B2 (en) 1999-12-16
CZ323497A3 (cs) 1998-03-18
TR199801562T2 (tr) 1998-10-21
ATE242634T1 (de) 2003-06-15
TW427887B (en) 2001-04-01
DE69628645D1 (de) 2003-07-17
AU5389796A (en) 1996-10-30
CN1181010A (zh) 1998-05-06
JPH11503459A (ja) 1999-03-26
NZ305784A (en) 2001-03-30
DE69628645T2 (de) 2004-05-13
PL322733A1 (en) 1998-02-16
HUP9801532A3 (en) 1999-05-28
NO974695D0 (no) 1997-10-10
SK138497A3 (en) 1998-05-06
CA2217952A1 (en) 1996-10-17
IL117875A0 (en) 1996-08-04

Similar Documents

Publication Publication Date Title
TR199701147T1 (tr) Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim.
TR199701148T1 (tr) Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim.
ATE233735T1 (de) Neue phenanthridine
ES2038659T3 (es) Composicion farmaceutica antimicrobiana topica que comprende un compuesto de plata y un azol.
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
ES8500242A1 (es) Procedimiento para la preparacion de derivados de imidazol
TR199901768T2 (tr) Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit.
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
AU2291097A (en) Novel phenanthridines substituted in the 6 position
CA2132001A1 (en) Methods of treating cancer using modified c-reactive protein
NO975661L (no) Anvendelse av bis-1,2,4-triazoler for fremstilling av et medikament for behandling av cancer
CA2368618A1 (en) Method of enhancing the efficacy of anti-tumor agents
MX9800944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.
MX9301083A (es) Complejos de quelato y procesos para su preparacion.
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
ES2118945T3 (es) Derivados de melamina utilizados en el tratamiento del cancer.
TR199802033T2 (tr) Böcek öldürücü siprodinil ve miklobutanil bilesimi.
DE59108566D1 (de) Heteroarylmethylbenzole-Aromatasehemmer
ATE323475T1 (de) D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
MX9707810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimiento de virus y canceres.
GB1254948A (en) Antivirial substance